Aptar Group, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, ...
Cardamyst is now FDA approved as a self-administered intranasal treatment for acute episodes of paroxysmal supraventricular tachycardia.
The FDA approved Milestone Pharmaceuticals' Cardamyst nasal spray for acute episodes of PSVT in adults. First treatment for ...
The self-administered treatment rapidly converts patients into sinus rhythm and may reduce trips to the hospital.
MedPage Today on MSN
Etripamil gets FDA approval for at-home tachycardia conversion
The FDA approved etripamil (Cardamyst) nasal spray for at-home treatment of paroxysmal supraventricular tachycardia (PSVT), ...
CARDAMYST nasal spray is a novel and rapid-acting calcium channel blocker delivered when needed to treat often highly ...
Sinus arrhythmia is the variation in heart rate attributable to respiration. Fox and Forges (1985) have found that the “amplitude” of sinus arrhythmia measured near birth is correlated with ...
A link exists between acute alcohol consumption and cardiac arrhythmias, particularly sinus tachycardia, a study published in European Heart Journal suggests. For the study, German researchers ...
SANTA CLARA, Calif., September 08, 2025--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, ...
Dr. Kathleen Maginot answers the question: 'Abnormal Heart Rhythms in Children?' — -- Question: What types of abnormal heart rhythms are more common in children? Answer :There are many ...
A harmless early extra heartbeat and a chaotic, racing, potentially lethal heart rhythm are obviously two different things. Yet, both fit the medical definition of an arrhythmia. "The majority of ...
TipRanks on MSN
HeartBeam (NASDAQ: BEAT) secures FDA 510(k) clearance for 12-lead ECG synthesis software following successful appeal
Austin, Texas, United States, December 10th, 2025, FinanceWire HeartBeam (NASDAQ: BEAT), a medical technology company focused ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results